4.7 Article

MicroRNA and circRNA Expression Analysis in a Zbtb1 Gene Knockout Monoclonal EL4 Cell Line

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2021.706919

关键词

Zbtb1; EL4; microRNA; circRNA; RNA-seq

资金

  1. National Key Research and Development Program of China [2017YFD0501000, 2017YFD0500400]
  2. National Natural Science Foundation of China [31672528, 31700763, 81760287, 31941018, 32072897]
  3. Science and Technology Development Program of Jilin Province [20180201040NY, 20190301042NY, 20200402041NC]
  4. Science and Technology Project of the Education Department of Jilin Province during the 13th Five-year Plan [JJKH20200360KJ]

向作者/读者索取更多资源

By using CRISPR-Cas9 technique to construct Zbtb1-deleted EL4 cell lines, this study identified a significant number of differentially expressed microRNA and circRNA between normal and gene deletion groups. Further analysis revealed regulatory relationships between miRNA and circRNA. This research provides potential targets for drug development and clinical treatment of T-cell lymphoma.
Zinc finger and BTB domain containing 1(Zbtb1) is a transcriptional suppressor protein, and a member of the mammalian Zbtb gene family. Previous studies have shown that Zbtb1 is essential for T-cell development. However, the role of Zbtb1 in T-cell lymphoma is undetermined. In this study, an EL4 cell line with Zbtb1 deletion was constructed using the CRISPR-Cas9 technique. The expression profiles of microRNA and circRNA produced by the control and gene deletion groups were determined by RNA-seq. In general, 24 differentially expressed microRNA and 16 differentially expressed circRNA were found between normal group and gene deletion group. Through further analysis of differentially expressed genes, GO term histogram and KEGG scatter plot were drawn, and three pairs of miRNA and circRNA regulatory relationships were found. This study describes the differentially expressed microRNA and circRNA in normal and Zbtb1-deficient EL4 cell lines, thus providing potential targets for drug development and clinical treatment of T-cell lymphoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据